Global Hematopoietic Stem Cells (HSCs) Market Research Report 2012-2023

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 Leukocyte

1.2.1.2 Lymphocytes

1.2.1.3 Red Blood Cells

1.2.1.4 Platelets

1.2.2 by Application

1.2.2.1 Blood System Diseases

1.2.2.2 Autoimmune Diseases

1.2.2.3 Others

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Leukocyte Market, 2012-2017

4.1.2 Lymphocytes Market, 2012-2017

4.1.3 Red Blood Cells Market, 2012-2017

4.1.4 Platelets Market, 2012-2017

4.2 Market Forecast

4.2.1 Leukocyte Market Forecast, 2018-2023

4.2.2 Lymphocytes Market Forecast, 2018-2023

4.2.3 Red Blood Cells Market Forecast, 2018-2023

4.2.4 Platelets Market Forecast, 2018-2023

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Blood System Diseases Market, 2012-2017

5.1.2 Autoimmune Diseases Market, 2012-2017

5.1.3 Others Market, 2012-2017

5.2 Market Forecast

5.2.1 Blood System Diseases Market Forecast, 2018-2023

5.2.2 Autoimmune Diseases Market Forecast, 2018-2023

5.2.3 Others Market Forecast, 2018-2023

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2017

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2017

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2017

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2017

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2017

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2018-2023

6.2.2 North America Market Forecast, 2018-2023

6.2.3 Europe Market Forecast, 2018-2023

6.2.4 South America Market Forecast, 2018-2023

6.2.5 Middle East & Africa Market Forecast, 2018-2023

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Kite Pharma Inc.

8.1.2 Profile

8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.2 Thermo Fisher Scientific

8.2.1 Profile

8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.3 PromoCell

8.3.1 Profile

8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.4 CellGenix Technologie Transfer GmbH

8.4.1 Profile

8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.5 Cesca Therapeutics Inc.

8.5.1 Profile

8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.6 R&D Systems

8.6.1 Profile

8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.7 Genlantis

8.7.1 Profile

8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.8 Lonza Group Ltd.

8.8.1 Profile

8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.9 TiGenix N.V.

8.9.1 Profile

8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.10 ScienCell Research Laboratories

8.10.1 Profile

8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.11 China Cord Blood Corporation

8.12 Vcanbio

8.13 Boyalife

8.14 Beike Biotechnology

9 Conclusion

Table Products Segment of Hematopoietic Stem Cells (HSCs)

Table Leukocyte Overview

Table Lymphocytes Overview

Table Red Blood Cells Overview

Table Platelets Overview

Table Global Hematopoietic Stem Cells (HSCs) Market by Type, 2011-2022 (USD Million)

Table Application Segment of Hematopoietic Stem Cells (HSCs)

Table Blood System Diseases Overview

Table Autoimmune Diseases Overview

Table Others Overview

Table Global Hematopoietic Stem Cells (HSCs) Market by Application, 2011-2022 (USD Million)

Table Global Hematopoietic Stem Cells (HSCs) Market by Region, 2011-2022 (USD Million)

Table Cost of Hematopoietic Stem Cells (HSCs)

Table Market Dynamics

Table Policy of Hematopoietic Stem Cells (HSCs)

Table GDP of Major Countries

Table Leukocyte CAGR by Revenue and Volume, 2012-2017

Table Lymphocytes CAGR by Revenue and Volume, 2012-2017

Table Red Blood Cells CAGR by Revenue and Volume, 2012-2017

Table Platelets CAGR by Revenue and Volume, 2012-2017

Table Leukocyte CAGR by Revenue and Volume, 2012-2022

Table Lymphocytes CAGR by Revenue and Volume, 2012-2022

Table Red Blood Cells CAGR by Revenue and Volume, 2012-2022

Table Platelets CAGR by Revenue and Volume, 2012-2022

Table Blood System Diseases CAGR by Revenue and Volume, 2012-2017

Table Autoimmune Diseases CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017